Beaumont Financial Partners, LLC Verastem, Inc. Transaction History
Beaumont Financial Partners, LLC
- $1.04 Billion
- Q3 2022
A detailed history of Beaumont Financial Partners, LLC transactions in Verastem, Inc. stock. As of the latest transaction made, Beaumont Financial Partners, LLC holds 48,000 shares of VSTM stock, worth $156,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,000
Previous 48,000
-0.0%
Holding current value
$156,000
Previous $56,000
26.79%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding VSTM
# of Institutions
5Shares Held
297KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY225KShares$731,2500.14% of portfolio
-
Eaton Vance Management Boston, MA20KShares$65,0000.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.99KShares$9,7010.0% of portfolio
-
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L21.07KShares$3,4900.0% of portfolio
About Verastem, Inc.
- Ticker VSTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 210,000,000
- Market Cap $683M
- Description
- Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...